Charles River Laboratories International, Inc. (CRL) vs Insulet Corp. (PODD)
PODD leads on 9 of 13 compared metrics.
A side-by-side comparison of Charles River Laboratories International, Inc. and Insulet Corp. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of June 25, 2026. The ● marks the stronger figure on each row (cheaper multiple, higher margin/return).
CRL
Charles River Laboratories International, Inc.
$202.10Healthcare
PODD
Insulet Corp.
$148.88Healthcare
Total return — CRL vs PODD
growth of $100 · last 19yCRL +291.5%PODD +832.8%PODD compounded faster
CRL PODD
CRL vs PODD: by the numbers
- •PODD is the larger company ($10.31B vs $9.73B market cap).
- •PODD is profitable (10.44% net margin) while CRL runs a net loss (-4.59%).
- •PODD grew revenue faster over the past five years (24.79% vs 5.77% CAGR).
Which is better, CRL or PODD?
Metric tally: CRL 4 · PODD 9It depends on what you're optimizing for:
GrowthPODD(faster 5Y revenue CAGR)
QualityPODD(higher ROIC)
Metrics side by side
Valuation
| Metric | CRL | PODD |
|---|---|---|
| P/E ratio | — | 34.62 |
| Forward P/E | 16.40● | 18.35 |
| P/S ratio | 2.46● | 3.60 |
| P/B ratio | 3.36● | 8.02 |
| PEG ratio | — | 0.35 |
| EV / EBITDA | 43.91 | 18.99● |
| FCF yield | 3.96% | 3.94% |
Profitability
| Metric | CRL | PODD |
|---|---|---|
| Gross margin | 31.86% | 71.01%● |
| Operating margin | 11.77% | 17.48%● |
| Net margin | -4.59% | 10.44%● |
| ROE | -6.28% | 23.25%● |
| ROIC | 8.36% | 13.62%● |
Growth (annualized)
| Metric | CRL | PODD |
|---|---|---|
| Revenue CAGR (5Y) | 5.77% | 24.79%● |
| EPS CAGR (5Y) | -40.99% | 99.91%● |
| FCF CAGR (5Y) | -3.98% | 79.41%● |
| Total return CAGR (5Y) | -11.24%● | -11.68% |
Frequently asked
- Which is better, CRL or PODD?
- It depends on your goal. growth: PODD (faster 5Y revenue CAGR); quality: PODD (higher ROIC). Across all compared metrics, PODD leads 9 to 4.
- Which has grown faster, CRL or PODD?
- Over the past five years, PODD grew revenue faster — CRL at a 5.77% CAGR versus PODD at 24.79%.
- Is CRL or PODD more profitable?
- PODD runs the higher net margin — CRL at -4.59% versus PODD at 10.44%.
- Which has been the better investment, CRL or PODD?
- Over the past 10-year, PODD delivered the higher annualized total return — CRL at 9.66% versus PODD at 17.96%. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Charles River Laboratories International P/E ratioInsulet P/E ratioCharles River Laboratories International dividend yieldInsulet dividend yieldCharles River Laboratories International ROEInsulet ROECharles River Laboratories International operating marginInsulet operating marginCharles River Laboratories International revenue growthInsulet revenue growthCharles River Laboratories International free cash flowInsulet free cash flow
Charles River Laboratories International & Insulet appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified June 25, 2026.